141 related articles for article (PubMed ID: 30390330)
1. Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis: Dynamics of essential motions and free-energy landscape analysis.
Singh A; Somvanshi P; Grover A
J Cell Biochem; 2019 May; 120(5):7386-7402. PubMed ID: 30390330
[TBL] [Abstract][Full Text] [Related]
2. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis.
Rehman AU; Khan MT; Liu H; Wadood A; Malik SI; Chen HF
J Chem Inf Model; 2019 Apr; 59(4):1584-1597. PubMed ID: 30810312
[TBL] [Abstract][Full Text] [Related]
4. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
[TBL] [Abstract][Full Text] [Related]
5. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
Zhang S; Chen J; Shi W; Liu W; Zhang W; Zhang Y
Emerg Microbes Infect; 2013 Jun; 2(6):e34. PubMed ID: 26038471
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide.
Yang J; Liu Y; Bi J; Cai Q; Liao X; Li W; Guo C; Zhang Q; Lin T; Zhao Y; Wang H; Liu J; Zhang X; Lin D
Mol Microbiol; 2015 Mar; 95(5):791-803. PubMed ID: 25430994
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid.
Vallejos-Sánchez K; Lopez JM; Antiparra R; Toscano E; Saavedra H; Kirwan DE; Amzel LM; Gilman RH; Maruenda H; Sheen P; Zimic M
Sci Rep; 2020 May; 10(1):8356. PubMed ID: 32433489
[TBL] [Abstract][Full Text] [Related]
8. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
[TBL] [Abstract][Full Text] [Related]
10. Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of
Khan MT; Rehaman AU; Junaid M; Malik SI; Wei DQ
Comput Struct Biotechnol J; 2018; 16():379-387. PubMed ID: 30402208
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
[TBL] [Abstract][Full Text] [Related]
13. Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide.
Shi W; Cui P; Niu H; Zhang S; Tønjum T; Zhu B; Zhang Y
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30858213
[TBL] [Abstract][Full Text] [Related]
14. Structural and Mechanistic Insights into
Saw WG; Leow CY; Harikishore A; Shin J; Cole MS; Aragaw WW; Ragunathan P; Hegde P; Aldrich CC; Dick T; Grüber G
ACS Infect Dis; 2022 Jul; 8(7):1324-1335. PubMed ID: 35731701
[No Abstract] [Full Text] [Related]
15. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
Gopal P; Nartey W; Ragunathan P; Sarathy J; Kaya F; Yee M; Setzer C; Manimekalai MSS; Dartois V; Grüber G; Dick T
ACS Infect Dis; 2017 Nov; 3(11):807-819. PubMed ID: 28991455
[TBL] [Abstract][Full Text] [Related]
16. Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.
Dillon NA; Peterson ND; Feaga HA; Keiler KC; Baughn AD
Sci Rep; 2017 Jul; 7(1):6135. PubMed ID: 28733601
[TBL] [Abstract][Full Text] [Related]
17. Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe
Nangraj AS; Khan A; Umbreen S; Sahar S; Arshad M; Younas S; Ahmad S; Ali S; Ali SS; Ali L; Wei DQ
Front Mol Biosci; 2021; 8():633365. PubMed ID: 34095218
[TBL] [Abstract][Full Text] [Related]
18. Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of
Sheik Amamuddy O; Musyoka TM; Boateng RA; Zabo S; Tastan Bishop Ö
Comput Struct Biotechnol J; 2020; 18():1103-1120. PubMed ID: 32489525
[TBL] [Abstract][Full Text] [Related]
19. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N.
Junaid M; Khan MT; Malik SI; Wei DQ
J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
